Radiology Partners leads the sector, employing 70.4% of private equity-affiliated radiologists, followed by LucidHealth (8.2%) and U.S. Radiology Specialists (6.7%). The study also reported that private equity-backed practices accounted for 16% of the nation's 21,556 imaging locations. Researchers attribute radiology's appeal to private equity to its reliance on advanced technology, increasing demand, and strong reimbursement rates. While private equity investment may enhance IT infrastructure and expand imaging access, the long-term effects on healthcare delivery, patient outcomes, and workforce dynamics remain unclear. Subscribe to our Newsletter to increase your edge. Don't worry about the news anymore, through our newsletter you'll receive weekly access to what is happening. Join 120,000 other PE professionals today....

Sponsor content from Siemens Healthineers....

Sirona Medical, a company developing an 'operating system' for digital radiology, has acquired Nines ' a company that has developed FDA-cleared analysis and triage algorithms. This acquisition comes during a somewhat shaky moment in AI-based radiology. But Sirona is betting this move proves out its thesis: to bring AI into the clinical workflow, we need to rebuild things from the ground up. To understand where Sirona and Nines fit together, think about the IT behind radiology as a layer cake. The first layer of that cake is made of medical image databases. The second layer is software that radiologists interact with on a day-to-day basis, like viewing or reporting software. The third consists of AI algorithms that can search for patterns in those images or help doctors make decisions. The company has created algorithms that it claims can actually aid in physician decision-making. One of those algorithms allows scientists to measure the size of lung nodules (abnormal growths) to help detect respiratory diseases. The other algorithm evaluates CT images of the brain for signs of intracranial hemorrhage and mass effect. The goal is to help doctors triage patients. (Both algorithms have received FDA 510(k) clearance.)...

Street Talk can reveal Livingbridge agreed a deal to take a majority stake in Everlight over the weekend, buying the large stake owned by Intermediate Capital Group and investing alongside the group’s management team and doctor shareholders. The deal is understood to value Everlight at more than $500m, representing a big payday for departing shareholder ICG and a significant step-up when it comes to Livingbridge’s investments in the local market. Everlight ticks both boxes. The group, which offers diagnostic services to hospitals and other health providers, was founded in Australia as Imaging Partners Online in 2006, before expanding into New Zealand and the United Kingdom (in 2010). Subscribe to our Newsletter to increase your edge. Don’t worry about the news anymore, through our newsletter you’ll receive weekly access to what is happening. Join 120,000 other PE professionals today. ICG, which bought into the business in 2016, had Rothschild & Co’s bankers run an auction to identify the buyer. The search started nearly two years ago, before it was paused to let the business and bidders’ deal with implications from the COVID-19 pandemic. It restarted in recent months, with a confirmation of interest at the end of June....